Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant-related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623521 | PMC |
http://dx.doi.org/10.1111/jdi.13884 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!